Evidence map›Paper›PMID 27233051›Full record

ArticlePLoS genetics2016

Keap1-Independent Regulation of Nrf2 Activity by Protein Acetylation and a BET Bromodomain Protein.

Nirmalya Chatterjee, Min Tian, Kerstin Spirohn, Michael Boutros, Dirk Bohmann

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Role of BET Proteins in Inflammation and CNS Diseases.Frontiers in molecular biosciences · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Catalpol Exerts an Anti-Epilepticus Effect, Possibly by Regulating the Nrf2-Keap1-ARE Signaling Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  17. Review
  18. BET-ting on Nrf2: How Nrf2 Signaling can Influence the Therapeutic Activities of BET Protein Inhibitors.BioEssays : news and reviews in molecular, cellular and developmental biology · 2018
    Review
  19. Organic Solute Transporter α-β Protects Ileal Enterocytes From Bile Acid-Induced Injury.Cellular and molecular gastroenterology and hepatology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Nirmalya ChatterjeeDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, New York, United States of America.
Min TianDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, New York, United States of America.
Kerstin SpirohnDivision of Signaling and Functional Genomics, German Cancer Research Center (DKFZ) and Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Michael BoutrosDivision of Signaling and Functional Genomics, German Cancer Research Center (DKFZ) and Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Dirk BohmannDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, New York, United States of America.
University of Rochester Medical Center · USGerman Cancer Research Center · DEHeidelberg University · DE

Funding

Redox Signaling and Stem Cell FunctionR01GM100196 · NIGMS · UNIVERSITY OF ROCHESTER · PI BOHMANN, DIRK, JASPER, HEINRICH · 2012 to 2015
$1.7M
Nrf2 as a regulator of health span and agingR01AG039753 · NIA · UNIVERSITY OF ROCHESTER · PI BOHMANN, DIRK · 2011 to 2015
$1.6M
NIA NIH HHS R01 AG039753NIGMS NIH HHS R01 GM100196
6 · The paper itself

Abstract

Mammalian BET proteins comprise a family of bromodomain-containing epigenetic regulators with complex functions in chromatin organization and gene regulation. We identified the sole member of the BET protein family in Drosophila, Fs(1)h, as an inhibitor of the stress responsive transcription factor CncC, the fly ortholog of Nrf2. Fs(1)h physically interacts with CncC in a manner that requires the function of its bromodomains and the acetylation of CncC. Treatment of cultured Drosophila cells or adult flies with fs(1)h RNAi or with the BET protein inhibitor JQ1 de-represses CncC transcriptional activity and engages protective gene expression programs. The mechanism by which Fs(1)h inhibits CncC function is distinct from the canonical mechanism that stimulates Nrf2 function by abrogating Keap1-dependent proteasomal degradation. Consistent with the independent modes of CncC regulation by Keap1 and Fs(1)h, combinations of drugs that can specifically target these pathways cause a strong synergistic and specific activation of protective CncC- dependent gene expression and boosts oxidative stress resistance. This synergism might be exploitable for the design of combinatorial therapies to target diseases associated with oxidative stress or inflammation.

Indexed as

AcetylationAnimalsAzepinesDisease Models, AnimalDrosophila melanogasterDrosophila ProteinsHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Nuclear ProteinsOxidative StressProteolysisRepressor ProteinsTranscription FactorsTriazolesAzepinescnc protein, DrosophilaDrosophila Proteinsfs(1)h protein, Drosophila(+)-JQ1 compoundKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Nuclear ProteinsRepressor ProteinsTranscription FactorsTriazoles

Identifiers

PMID27233051
PMCPMC4883770
OpenAlexW2396956150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.